UNSPSC 51373424: Chlorpheniramine/codeine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373424 Chlorpheniramine/codeine/phenylephrine/phenylpropanolamine is a Commodity code under which state and local governments procure pharmaceutical products and related healthcare supplies, though recent activity shows the code captures a broader range of parenteral and emergency medical supplies than its name alone suggests. The Washington State Department of Corrections is soliciting parenteral products including intravenous solutions, parenteral nutrition preparations (TPN and PPN), and controlled substances for incarcerated individuals through an RFQ posted September 8, 2026, with response due October 7, 2026. State correctional agencies and county health departments are the primary issuing bodies soliciting under this code. The Washington DOC solicitation encourages participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses through state set-asides, with aspirational goals of 25% small business, 10% minority-owned, 6% women-owned, and 5% veteran-owned participation. Contractors must hold Washington State business licensure, pass NCIC clearance, and maintain substantial insurance including $1 million commercial general liability, $2 million professional liability, $1 million business automobile liability, and $2 million cyber liability.

Recent activity clusters in Washington State and Florida. The Washington DOC contract spans eight correctional facilities across three regions (West, Central, and East), with DOC anticipating multiple awards of up to three contractors per region for a term running November 26, 2026 through June 30, 2030. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though the response deadline listed (July 26, 2023) predates the posting date and appears to be a historical record. The Washington solicitation requires parenteral nutrition bags delivered within 24 hours of order and other parenteral products within 8 hours for the first 24-hour supply, with pricing fixed throughout the initial two-year term.